DE59701078D1 - Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen - Google Patents

Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen

Info

Publication number
DE59701078D1
DE59701078D1 DE59701078T DE59701078T DE59701078D1 DE 59701078 D1 DE59701078 D1 DE 59701078D1 DE 59701078 T DE59701078 T DE 59701078T DE 59701078 T DE59701078 T DE 59701078T DE 59701078 D1 DE59701078 D1 DE 59701078D1
Authority
DE
Germany
Prior art keywords
liver diseases
prevention
treatment
peptide bradykinin
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59701078T
Other languages
German (de)
English (en)
Inventor
Holger Heitsch
Adalbert Wagner
Klaus Wirth
Max Hropot
Martin Bickel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996120509 external-priority patent/DE19620509A1/de
Priority claimed from DE19632042A external-priority patent/DE19632042A1/de
Priority claimed from DE19639303A external-priority patent/DE19639303A1/de
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of DE59701078D1 publication Critical patent/DE59701078D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE59701078T 1996-05-22 1997-05-20 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen Expired - Lifetime DE59701078D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE1996120509 DE19620509A1 (de) 1996-05-22 1996-05-22 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19632042A DE19632042A1 (de) 1996-08-08 1996-08-08 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19639303A DE19639303A1 (de) 1996-09-25 1996-09-25 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
US08/858,550 US5786365A (en) 1996-05-22 1997-05-19 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

Publications (1)

Publication Number Publication Date
DE59701078D1 true DE59701078D1 (de) 2000-03-09

Family

ID=27438369

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59701078T Expired - Lifetime DE59701078D1 (de) 1996-05-22 1997-05-20 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen

Country Status (23)

Country Link
US (1) US5786365A (https=)
EP (2) EP0808627A2 (https=)
JP (1) JP4034849B2 (https=)
CN (1) CN1176102A (https=)
AT (1) ATE189389T1 (https=)
AU (1) AU2351197A (https=)
BR (1) BR9703367A (https=)
CA (1) CA2205780A1 (https=)
CZ (1) CZ154697A3 (https=)
DE (1) DE59701078D1 (https=)
DK (1) DK0808628T3 (https=)
ES (1) ES2144291T3 (https=)
GR (1) GR3033048T3 (https=)
HR (1) HRP970278A2 (https=)
HU (1) HUP9700913A1 (https=)
ID (1) ID18447A (https=)
IL (1) IL120862A0 (https=)
NO (1) NO972311L (https=)
PL (1) PL320134A1 (https=)
PT (1) PT808628E (https=)
SI (1) SI0808628T1 (https=)
SK (1) SK63097A3 (https=)
TR (1) TR199700392A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935581A (en) * 1996-07-24 1999-08-10 Kapadia; Govind J. Inhibitory effects of synthetic and natural colorants on carcinogenesis
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19712960A1 (de) * 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
US6767889B1 (en) 1998-11-10 2004-07-27 Temple University Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
EP1044012B1 (en) 1998-11-10 2006-05-03 Temple University of the Commonwealth System of Higher Education Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5
AU773862B2 (en) * 1998-11-10 2004-06-10 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
US6869931B1 (en) 1998-12-16 2005-03-22 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
US6994852B1 (en) 1999-11-12 2006-02-07 Temple University-Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
US6445588B1 (en) 2001-01-02 2002-09-03 Motorola, Inc. Apparatus and method for securing a printed circuit board to a base plate
RU2006124843A (ru) 2003-12-12 2008-01-20 Уайт (Us) Хинолины, пригодные для лечения сердечно-сосудистого заболевания
AU2006228957A1 (en) * 2005-04-01 2006-10-05 Methylgene Inc. Inhibitors of histone deacetylase
WO2012006103A2 (en) 2010-06-29 2012-01-12 Jennifer Digrazia Wound and bandage protection system and method
US12427067B2 (en) 2010-06-29 2025-09-30 Jennifer DiGrazia Wound and bandage protection system and method
US10517765B2 (en) 2010-06-29 2019-12-31 Jennifer DiGrazia Wound and bandage protection system and method
RU2514345C1 (ru) * 2012-10-09 2014-04-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования степени риска геморрагических осложнений при миниинвазивных хирургических вмешательствах на печени

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
AU686115B2 (en) * 1992-11-02 1998-02-05 Fujisawa Pharmaceutical Co., Ltd. Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
JP3049648B2 (ja) * 1993-12-13 2000-06-05 日立金属株式会社 加圧成形方法および加圧成形機
WO1996004251A1 (en) * 1994-08-03 1996-02-15 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic compound

Also Published As

Publication number Publication date
ID18447A (id) 1998-04-09
HU9700913D0 (en) 1997-07-28
MX9703725A (es) 1997-11-29
SI0808628T1 (en) 2000-04-30
AU2351197A (en) 1997-11-27
HUP9700913A1 (hu) 1999-09-28
CA2205780A1 (en) 1997-11-22
SK63097A3 (en) 1997-12-10
US5786365A (en) 1998-07-28
NO972311D0 (no) 1997-05-21
ATE189389T1 (de) 2000-02-15
EP0808628A2 (de) 1997-11-26
JP4034849B2 (ja) 2008-01-16
IL120862A0 (en) 1997-09-30
PL320134A1 (en) 1997-11-24
DK0808628T3 (da) 2000-06-26
CN1176102A (zh) 1998-03-18
EP0808627A2 (de) 1997-11-26
GR3033048T3 (en) 2000-08-31
CZ154697A3 (en) 1997-12-17
HRP970278A2 (en) 1998-04-30
TR199700392A2 (xx) 1997-12-21
EP0808628B1 (de) 2000-02-02
BR9703367A (pt) 1998-09-15
NO972311L (no) 1997-11-24
PT808628E (pt) 2000-05-31
EP0808628A3 (de) 1998-01-14
JPH1045624A (ja) 1998-02-17
ES2144291T3 (es) 2000-06-01

Similar Documents

Publication Publication Date Title
DE59701078D1 (de) Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
PT863136E (pt) Derivados de azetidina e de pirrolidina
DE19680619D2 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
BR0011446A (pt) Método de inibição da agregação de proteìna amilóide e formação de imagem de depósitos de amilóide usando derivados de isoindolina
NO20014925D0 (no) Farmasöytiske forbindelser
ATE88894T1 (de) Methode zur behandlung von kachexie und bestimmte dafuer anzuwendende verbindungen.
DE69132713D1 (de) Benzylidenthiazolidinderivate, ihre Herstellung und ihre Anwendung als Lipidperoxid-Inhibitoren
NO951968D0 (no) 11,21-bisfenyl-19-norpregnan-derivater
ATE284692T1 (de) Verwendung von nicht-peptidischen bradykinin- antagonisten zur herstellung von arzneimitteln zur behandlung und prävention der alzheimerischen krankheit
ATE304522T1 (de) Verfahren zur hemmung von amyloidprotein aggregation und zur diagnostischen nachweis von amyloidablagerung unter verwendung von aminoindanderivaten
OA09027A (fr) Procédé d'inhibition. d'un virus
NO975903D0 (no) N-benzylpiperazin-forbindelser, fremgangsmåte ved fremstilling derav, samt farmasöytiske blandinger
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
PT955286E (pt) Derivados do di-hidro ou tetra-hidronaftaleno tendo uma actividade (ani-)estrogenica
DE69911373D1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
DE69916577D1 (de) Azetidincarboxamid-derivate zur behandlung von zns störungen
ATE250413T1 (de) 2-aminotetraline zur behandlung von glaukom
ATE292950T1 (de) Verwendung der 4,6-dimethoxyindol-2-carbonsäure zur induzierung und/oder stimulation des haarwachstums und/oder zur verhinderung des haarausfalls
ATE314339T1 (de) Polyhydroxyphenolderivate und mittel zur vorbeugung und therapie von knochen- und knorpelkrankheiten die diese enthalten
NZ505994A (en) Statin-matrix metalloproteinase inhibitor combinations useful fro treating vascular diseases
DE50104100D1 (de) Verwendung spezieller verbindungen zur prophylaxe und therapie von hepatitis c
ATE220665T1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
ES2114477A1 (es) Nuevas cafalosporinas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition